NCT01551771View on ClinicalTrials.gov

GW824575 First Time in Human

PHASE1TerminatedINTERVENTIONAL

Enrollment

16

Participants

Timeline

Start Date

February 1, 2012

Primary Completion Date

April 12, 2012

Study Completion Date

April 12, 2012

Conditions

Retinal Diseases

Interventions

DRUG

GW824575

Investigational treatment - Swedish Orange Coloured, opaque hard gelatin capsule

DRUG

GW824575 matched-placebo

Placebo

Trial Locations (1)

NW10 7EW

GSK Investigational Site, London

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY